Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

1.25
-0.0400-3.10%
Post-market: 1.290.0400+3.20%19:30 EDT
Volume:481.12K
Turnover:601.26K
Market Cap:56.43M
PE:-1.61
High:1.33
Open:1.31
Low:1.17
Close:1.29
52wk High:1.69
52wk Low:0.5011
Shares:45.14M
Float Shares:21.74M
Volume Ratio:1.34
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-3.56
PE(LYR):-1.51

Loading ...

TELA Bio Director Joseph H. Capper Acquires Common Shares Worth USD 88,845.00

Reuters
·
Sep 19

TELA Bio Faces NASDAQ Delisting Notice After Failing $1 Minimum Bid Rule

Reuters
·
Sep 19

Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA), Oscar Health (OSCR) and Brookdale Senior Living (BKD)

TIPRANKS
·
Sep 17

Insider Move at TELA Bio Signals Growing Confidence From the Top

TIPRANKS
·
Sep 17

TELA Bio Director Joseph H. Capper Acquires USD 78,449 in Common Shares

Reuters
·
Sep 17

TELA Bio Announces Special Shareholder Meeting

Reuters
·
Sep 05

Analyst Reaffirms Buy on TELA Bio, Citing Restructuring-Driven Cost Savings and Steady $2 Price Target

TIPRANKS
·
Sep 01

TELA Bio - Roberto Cuca Steps Down as COO and CFO Effective August 31, 2026

THOMSON REUTERS
·
Aug 31

TELA Bio - Anticipates One-Time Restructuring Charge of About $1.50 Mln in Q3 2026

THOMSON REUTERS
·
Aug 31

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

THOMSON REUTERS
·
Aug 31

TELA Bio - to Reduce Headcount by About 20%

THOMSON REUTERS
·
Aug 31

TELA Bio - to Reduce Annual Operating Expenses by About $17 Mln

THOMSON REUTERS
·
Aug 31

TELA Bio - Expects Cost Reduction Initiative to Extend Cash Runway into 2028

THOMSON REUTERS
·
Aug 31

TELA Bio CEO Heather Getz Acquires 12,500 Common Shares Valued at $8,311.25

Reuters
·
Aug 20

TELA Bio CEO Makes Bold Move Signaling Fresh Confidence in the Company

TIPRANKS
·
Aug 18

TELA Bio CEO Heather C. Getz Acquires Common Shares Worth $10,467

Reuters
·
Aug 18

Tenon Medical Q2 Revenue Jumps on Higher Surgical Procedure Volume

Reuters
·
Aug 14

TELA Bio Amends 8-K to Detail Former CEO Koblish Separation Benefits

Reuters
·
Aug 14

Sanara MedTech Q2 Revenue Rises on Soft-Tissue Product Growth

Reuters
·
Aug 12

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Sonida Senior Living (SNDA) and TELA Bio (TELA)

TIPRANKS
·
Aug 11